RecruitingNCT06698302
Validation of COMPAT-SF Spanish Translation
Sponsor
Methodist Health System
Enrollment
100 participants
Start Date
Sep 13, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- years or older in age
- Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
- Able to read and understand the study information in Spanish
- Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study
- Subject is willing and able to comply with the scheduled questionnaires
Exclusion Criteria1
- Subjects who do not meet the criteria in section 4.1
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALQuestionnaires
Administer translated COMPAT-SF questionnaires to Spanish-speaking CP patients
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06698302
Related Trials
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
NCT0346076910 locations
Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis
NCT075368412 locations
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
NCT056037025 locations
A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects
NCT072858631 location
Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis
NCT074185932 locations